| scholarly article | Q13442814 |
| P2093 | author name string | Ping Zhao | |
| Han-Mo Koo | |||
| Brian Cao | |||
| Jessica Kalbfleisch | |||
| Xudong Liang | |||
| P433 | issue | 4 | |
| P921 | main subject | monoclonal antibody | Q422248 |
| antibody | Q79460 | ||
| intoxication | Q18621601 | ||
| P304 | page(s) | 129-135 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Human Antibodies | Q26841893 |
| P1476 | title | Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model | |
| P478 | volume | 12 |
| Q35808793 | A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax |
| Q39958178 | A dual-purpose protein ligand for effective therapy and sensitive diagnosis of anthrax |
| Q39124815 | A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro. |
| Q36378590 | A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques |
| Q34033505 | An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin |
| Q34433313 | An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. |
| Q28392066 | An overview of anthrax infection including the recently identified form of disease in injection drug users |
| Q38446682 | An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis |
| Q33783323 | Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits |
| Q35599606 | Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity |
| Q37262118 | Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax |
| Q35610439 | Antibodies against anthrax: mechanisms of action and clinical applications |
| Q36911369 | Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays |
| Q33285349 | High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation |
| Q59789589 | Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax |
| Q24682011 | Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax |
| Q39017303 | Identification of two aberrant transcripts derived from a hybridoma with amplification of functional immunoglobulin variable genes |
| Q28383065 | In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity |
| Q28383094 | Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy |
| Q36482706 | MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen |
| Q34761514 | Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor |
| Q36099489 | Monoclonal antibodies and toxins--a perspective on function and isotype |
| Q28393072 | Monoclonal antibody therapies against anthrax |
| Q37333457 | Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody |
| Q26827489 | Obstructing toxin pathways by targeted pore blockage |
| Q37304034 | Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding |
| Q33306246 | Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin |
| Q37033046 | Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies |
| Q37586186 | Small molecule inhibitors of anthrax lethal factor toxin |
| Q39205816 | The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax. |
Search more.